Encompass Health (EHC)
(Delayed Data from NYSE)
$82.47 USD
-0.26 (-0.31%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $82.47 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth C Momentum A VGM
Price, Consensus and EPS Surprise
EHC 82.47 -0.26(-0.31%)
Will EHC be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for EHC based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for EHC
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
Why Encompass Health (EHC) is a Top Momentum Stock for the Long-Term
EHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
Other News for EHC
Encompass Health price target raised by $10 at Raymond James, here's why
Encompass Health Corp (EHC) Q1 2024 Earnings Call Transcript Highlights: Strong Performance and ...
Analysts Offer Insights on Healthcare Companies: Encompass Health (EHC), Universal Health (UHS) and Viking Therapeutics (VKTX)
Encompass Health’s Growth Trajectory Spurs Buy Rating and Increased Price Objective
Encompass Health price target raised by $2 at Mizuho, here's why